Monactil (Dexibuprofen)

Dexibuprofen, the active ingredient in Monactil, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It reduces pain, inflammation and fever, and is commonly used to manage mild to moderate musculoskeletal discomfort, dysmenorrhea and other short‑term pain conditions in adults.

GNH USA supplies Monactil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. This enables reliable procurement for diverse healthcare settings.

Dexibuprofen, an NSAID that inhibits cyclo‑oxygenase enzymes, is indicated for several pain‑related and inflammatory conditions.

- Mild to moderate pain: Provides analgesic relief for acute or chronic non‑specific pain. - Musculoskeletal inflammation: Decreases swelling and discomfort associated with sprains, strains and arthritis. - Fever: Lowers elevated body temperature in febrile states. - Dysmenorrhea: Relieves menstrual cramps and associated pelvic pain.

Dexibuprofen may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated blood pressure in susceptible individuals.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe hypersensitivity reactions, including anaphylaxis. - Renal impairment or acute kidney injury. - Cardiovascular events such as myocardial infarction or stroke. - Hepatic dysfunction with elevated transaminases.

Before using Dexibuprofen, consider the following safety measures.

- Assess gastrointestinal risk: avoid use in patients with active ulcers or a history of GI bleeding. - Evaluate cardiovascular status: use cautiously in individuals with hypertension, heart disease or stroke risk. - Monitor renal function: patients with chronic kidney disease should be observed closely. - Review concomitant medications: avoid concurrent use with other NSAIDs, anticoagulants or corticosteroids without medical guidance. - Pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding. - Store at ambient temperature: keep below 25 °C, retain in the original packaging, and protect from moisture and direct sunlight.

Dexibuprofen can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose aspirin: heightened renal and GI adverse effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in dehydrated patients. - Diuretics: potential for reduced efficacy and electrolyte imbalance. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk.